Clinical trial
Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid…
NCT00124449 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00124449 |
|---|---|
| Title | Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients |
| Official title | A Phase II Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients With Undifferentiated Arthritis Who Are at High Risk for the Development of RA |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | Abatacept, placebo |
| Enrollment | 56 |
| Start date | Feb 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Jul 28, 2005 |
| Last update posted | Apr 7, 2015 |
| Countries | Australia, Belgium, France, Germany, Italy, Mexico, Puerto Rico, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: